BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 8784276)

  • 1. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
    Lazarova Z; Yancey KB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin.
    Domloge-Hultsch N; Benson P; Gammon WR; Yancey KB
    Arch Dermatol; 1992 Aug; 128(8):1096-101. PubMed ID: 1379792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
    Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
    J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid.
    Lazarova Z; Salato VK; Lanschuetzer CM; Janson M; Fairley JA; Yancey KB
    J Am Acad Dermatol; 2008 Jun; 58(6):951-8. PubMed ID: 18396347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
    Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
    Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J; Shears E; Powell J; Wojnarowska F
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepiligrin cicatricial pemphigoid.
    Hsu RC; Lazarova Z; Lee HG; Tung YC; Yu HS
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):841-4. PubMed ID: 10775868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane.
    Shimizu H; Masunaga T; Ishiko A; Matsumura K; Hashimoto T; Nishikawa T; Domloge-Hultsch N; Lazarova Z; Yancey KB
    J Invest Dermatol; 1995 Mar; 104(3):370-3. PubMed ID: 7861004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid.
    Kelly SE; Wojnarowska F
    Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of unique subepidermal blistering disease with autoantibodies against a novel dermal 200-kD antigen.
    Kawahara Y; Matsuo Y; Hashimoto T; Nishikawa T
    Dermatology; 1998; 196(2):213-6. PubMed ID: 9568410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen.
    Kawahara Y; Zillikens D; Yancey KB; Marinkovich MP; Nie Z; Hashimoto T; Nishikawa T
    J Dermatol Sci; 2000 Jun; 23(2):93-102. PubMed ID: 10808126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
    Fine JD
    Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
    Leverkus M; Schmidt E; Lazarova Z; Bröcker EB; Yancey KB; Zillikens D
    Arch Dermatol; 1999 Sep; 135(9):1091-8. PubMed ID: 10490114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies.
    Olivry T; Bizikova P; Dunston SM; Bond R; Halliwell R; Loeffler A; Pucheu-Haston CM; Chen M; Marinkovich MP
    Vet Dermatol; 2010 Aug; 21(4):345-57. PubMed ID: 20456722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat direct immunofluorescence (DIF) test, using, 1 M NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction.
    Barnadas MA; Gelpi C; Curell R; de Moragas JM; Alomar A
    J Cutan Pathol; 1999 Jan; 26(1):37-41. PubMed ID: 10189243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.